> This is not the first time President Trump has tried to tie drug prices to what other countries pay. During Trump's first term, a court blocked a proposed international reference pricing program.

Thinking we might see the same outcome. And that Trump allies took short positions on pharma stocks.

It seems this is really about keeping drug prices about the same but increasing them for other countries.

Trump isn't one for details but I watched his announcement and the examples he rattled off seemed to have one thing in common, countries with single-buyer national insurance and subsidized prices to patients. A patient might pay $20 but the national insurance purchases the drugs at a higher price.